A deep understanding of current treatment challenges for people affected by blood cancers drives us to deliver meaningful advances to improve standards of care.
Acute Lymphoblastic Leukemia (ALL)
ALL occurs when too many early or immature forms of lymphocytes, a type of white blood cell, are made by the bone marrow. It is the most common type of cancer in children.10
Diffuse large B-cell lymphoma (DLBCL)
DLBCL is the most common type of non-Hodgkin lymphoma (NHL) in the U.S. and worldwide. The occurrence of DLBCL generally increases with age, with most patients diagnosed over 60.11
Mantle Cell Lymphoma (MCL)
MCL is typically an aggressive form of NHL that arises from cells originating in the outer edge of the lymph nodes called the mantle zone. In the U.S., MCL accounts for approximately six percent of all NHL cases.12
Multiple Myeloma (MM)
MM is a cancer of plasma cells, often categorized by recurring cycles of relapse and remission. It is the second most common blood cancer.13,14
Myelodysplastic Syndromes (MDS)
MDS are a group of blood disorders characterized by abnormal development of blood cells within the bone marrow. These disorders are considered a type of cancer.15
Myelofibrosis (MF)
MF is a rare disorder in which abnormal blood cells and fibrous tissue build up in the bone marrow.16